A conflict has developed between the Czech Republic's Health Minister, Daniela Filipiova, and the Parliament over the control of cold and influenza products containing pseudoephedrine. A recent draft law presented to the legislature now includes an amendment to classify the active ingredient as an addictive substance for prescription only. Ms Filipiova opposes this move, partly on the grounds that forcing more people with colds to visit physician surgeries is a waste of time and will increase the risk of other patients being infected.
The ingredient is used in the manufacture of the illegal narcotic methylamphetamine. The Health Minister argues that the new requirement for pharmacists to be shown an insurance card before selling cold or flu remedies will enable suspiciously large numbers of transactions to be monitored.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze